Maturitas
Volume 59, Issue 3 , Pages 249-258 , 20 March 2008

Effects of estradiol and norethisterone on lipids, insulin resistance and carotid flow

  • Cesar E. Fernandes

      Affiliations

    • ABC School of Medicine, São Paulo, Brazil
    • ,
  • Luciano M. Pompei

      Affiliations

    • ABC School of Medicine, São Paulo, Brazil
    • Corresponding Author InformationCorresponding author. Av. Indianopolis 2700, São Paulo 04062-003, Brazil. Tel.: +55 11 55894442; fax: +55 11 55894442.
    • ,
  • Rogério B. Machado

      Affiliations

    • Jundiaí School of Medicine, Jundiaí, Brazil
    • ,
  • José Arnaldo S. Ferreira

      Affiliations

    • ABC School of Medicine, São Paulo, Brazil
    • ,
  • Nilson R. Melo

      Affiliations

    • School of Medicine of the University of São Paulo, São Paulo, Brazil
    • ,
  • Sergio Peixoto

      Affiliations

    • ABC School of Medicine, São Paulo, Brazil
    • School of Medicine of the University of São Paulo, São Paulo, Brazil

Received 20 September 2007 ,Revised 29 January 2008 ,Accepted 5 February 2008.

References 

  1. ESHRE Capri Workshop Group . Hormones and cardiovascular health in women. Hum Reprod Update. 2006;12:483–497
  2. Dubey RK, Imthurn B, Barton M, Jackson EK. Vascular consequences of menopause and hormone therapy: importance of timing of treatment and type of estrogen. Cardiovasc Res. 2005;66:295–306
  3. Carr MC. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab. 2003;88:2404–2411
  4. Schneider JG, Tompkins C, Blumenthal RS, Mora S. The metabolic syndrome in women. Cardiol Rev. 2006;14:286–291
  5. Godsland IF, Crook D, Simpson R, et al. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism. N Engl J Med. 1990;323:1375–1381
  6. Lau TK, Wan D, Yim SF, Sanderson JE, Haines CJ. Prospective, randomized, controlled study of the effect of hormone replacement therapy on peripheral blood flow velocity in postmenopausal women. Fertil Steril. 1998;70:284–288
  7. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499–502
  8. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting glucose and insulin concentrations in man. Diabetologia. 1985;28:412–419
  9. Braun B, Rock PB, Zamudio S, et al. Women at altitude: short-term exposure to hypoxia and/or α1-adrenergic blockade reduces insulin sensitivity. J Appl Physiol. 2001;91:623–631
  10. Stampfer MJ, Colditz GA, Willett WC, et al. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses’ health study. N Engl J Med. 1991;325:756–762
  11. Manson JE, Hsia J, Johnson KC, et al. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med. 2003;349:523–534
  12. Salpeter SR, Walsh JM, Ormiston TM, et al. Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women. Diab Obes Metab. 2006;8(5):538–554
  13. Slopien R, Junik R, Meczekalski B, et al. Influence of hormonal replacement therapy on the regional cerebral blood flow in postmenopausal women. Maturitas. 2003;46(4):255–262
  14. Lopez-Jaramillo P, Diaz LA, Pardo A, et al. Estrogen therapy increases plasma concentrations of nitric oxide metabolites in postmenopausal women but increases flow-mediated vasodilation only in younger women. Fertil Steril. 2004;82(6):1550–1555
  15. Guo X, Razandi M, Pedram A, Kassab G, Levin ER. Estrogen induces vascular wall dilation: mediation through kinase signaling to nitric oxide and estrogen receptors alpha and beta. J Biol Chem. 2005;280:19704–19710
  16. Balci H, Altunyurt S, Acar B, Fadiloglu M, Kirkali G, Onvural B. Effects of transdermal estrogen replacement therapy on plasma levels of nitric oxide and plasma lipids in postmenopausal women. Maturitas. 2005;50:289–293
  17. De Leo V, la Marca A, Orlandi R, Crippa D, Setacci C, Petraglia F. Effects of estradiol alone or in combination with cyproterone acetate on carotid artery pulsatility index in postmenopausal women. Maturitas. 2003;46:219–224
  18. Atalay E, Karaali K, Akar M, et al. Early impact of hormone replacement therapy on vascular hemodynamics detected via ocular colour Doppler analysis. Maturitas. 2005;50:282–288
  19. Luckas MJ, Gleeve T, Biljan MM, et al. The effect of progestagens on the carotid artery pulsatility index in postmenopausal women on oestrogen replacement therapy. Eur J Obstet Gynecol Reprod Biol. 1998;76:221–224
  20. Hsia J, Langer RD, Manson JE, et al. Conjugated equine estrogens and coronary heart disease: the women's health initiative. Arch Intern Med. 2006;166:357–365
  21. Spellacy W, McLeod A, Buhi W, Birk S. Depot medroxyprogesterone acetate and carbohydrate metabolism: measurement of glucose, insulin and growth hormone after twelve months’ use. Fertil Steril. 1972;23:239–244
  22. Lobo RA, Bush T, Carr BR, Pickar JH. Effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate on plasma lipids and lipoproteins, coagulation factors, and carbohydrate metabolism. Fertil Steril. 2001;76:13–24
  23. Arruda CG, Aldrighi JM, Bortolotto LA, Alecrin IN, Ramires JA. Effects of estradiol alone and combined with norethisterone acetate on pulse-wave velocity in hypertensive postmenopausal women. Gynecol Endocrinol. 2006;22:557–563
  24. Lazar F, Costa-Paiva L, Pinto-Neto AM, Martinez EZ. Carotid and uterine vascular resistance in short-term hormone replacement therapy postmenopausal users. Maturitas. 2004;48:472–478
  25. Godsland IF. Oestrogens and insulin secretion. Diabetologia. 2005;48(11):2213–2220
  26. Sites CK, L’Hommedieu GD, Toth MJ, Brochu M, Cooper BC, Fairhurst PA. The effect of hormone replacement therapy on body composition, body fat distribution, and insulin sensitivity in menopausal women: a randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab. 2005;90:2701–2707
  27. Elkind-Hirsch KE, Sherman LD, Malinak R. Hormone replacement therapy alters insulin sensitivity in young women with premature ovarian failure. J Clin Endocrinol Metab. 1993;76:472–475
  28. Lindheim SR, Duffy DM, Kojima T, Vijod MA, Stanczyk FZ, Lobo RA. The route of administration influences the effect of estrogen on insulin sensitivity in postmenopausal women. Fertil Steril. 1994;62:1176–1180
  29. Dansuk R, Unal O, Karsidag YK, Turan C. Evaluation of the effects of various gestagens on insulin sensitivity, using homeostatic model assessment, in postmenopausal women on hormone replacement therapy. Gynecol Endocrinol. 2005;20:1–5
  30. Sumino H, Ichikawa S, Itoh H, et al. Hormone replacement therapy decreases insulin resistance and lipid metabolism in Japanese postmenopausal women with impaired and normal glucose tolerance. Horm Res. 2003;60:134–142
  31. Ishida Y, Mine T, Taguchi T. Effect of progestins with different glucocorticoid activity on bone metabolism. Clin Endocrinol (Oxf). 2008;68(3):423–428

PII: S0378-5122(08)00037-6

doi: 10.1016/j.maturitas.2008.02.001

Maturitas
Volume 59, Issue 3 , Pages 249-258 , 20 March 2008

Article Tools

* Image Usage & Resolution